Tyloxapol: Difference between revisions
No edit summary |
No edit summary |
||
| Line 53: | Line 53: | ||
With [[intraperitoneal injection]], tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of [[triglyceride]]-rich [[lipoprotein]]s. This mechanism is used to induce experimental [[hyperlipidemia]] in animals.<ref>{{cite pmid|12231215}}</ref> |
With [[intraperitoneal injection]], tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of [[triglyceride]]-rich [[lipoprotein]]s. This mechanism is used to induce experimental [[hyperlipidemia]] in animals.<ref>{{cite pmid|12231215}}</ref> |
||
Tyloxapol is the main active ingredient of the medical device Tacholiquin. Tacholiquin is an Expectorant designated for inhalation and instillation |
Tyloxapol is the main active ingredient of the medical device Tacholiquin. Tacholiquin is an Expectorant designated for inhalation and instillation reaching the upper and lower airways. |
||
Other brand names of pharmaceutical products containing Tyloxpol are: Exosurf, Alevaire |
Other brand names of pharmaceutical products containing Tyloxpol are: Exosurf, Alevaire |
||
==References== |
==References== |
||
{{reflist}} |
{{reflist}} |
||
Revision as of 16:20, 3 March 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.209.660 |
| Chemical and physical data | |
| Formula | (C15H21O(C2H4O)m)n |
| Molar mass | variable |
  (what is this?) (verify) | |
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type. It is used as a surfactant to aid liquefaction and removal of mucopurulent[citation needed] (containing mucus and pus) bronchopulmonary secretions,[1][2] administered by inhalation through a nebulizer[3] or with a stream of oxygen.
With intraperitoneal injection, tyloxapol also blocks plasma lipolytic activity, and thus the breakdown of triglyceride-rich lipoproteins. This mechanism is used to induce experimental hyperlipidemia in animals.[4]
Tyloxapol is the main active ingredient of the medical device Tacholiquin. Tacholiquin is an Expectorant designated for inhalation and instillation reaching the upper and lower airways. Other brand names of pharmaceutical products containing Tyloxpol are: Exosurf, Alevaire
References
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 8151722, please use {{cite journal}} with
|pmid=8151722instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 1555424, please use {{cite journal}} with
|pmid=1555424instead. - ^ Drugs.com: Tyloxapol definition
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12231215, please use {{cite journal}} with
|pmid=12231215instead.
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |